Skip to Main Content

BluMetric

  • CMISA posted an article
    Will produce a total of 26 self-contained water treatment units see more

    BluMetric Environmental Inc. announced that it has received a notice to proceed for production of its Mission Ready Water systems under the previously announced Rheinmetall Canada contract for the Canadian Armed Forces.

    In accordance with the contract, which is now valued at $12.2 million, BluMetric will produce a total of 26 self-contained water treatment units, their associated miscellaneous equipment units, and a portion of cold weather ancillary packages. Production will be at the Company’s Carp, Ontario facility and is expected to be delivered within the next 18 months.

    “Our team is thrilled to advance to this crucial stage of production and see the Canadian military’s commitment to our Mission Ready Water solutions,” said Scott MacFabe, Chair & CEO of BluMetric. “This notice to proceed is a testament to our ability to deliver on a high-quality and robust system that meets the highly demanding needs of a military organization. We look forward to executing this contract while further strengthening our military partnerships worldwide.”

    View Full Article Here

  • CMISA posted an article
    The Offering comprised the issuance by the Company of 4,375,000 common shares see more

     BluMetric Environmental Inc. (“BluMetric” or the “Company”) (TSXV:BLM, OTCQX:BLMWF) is pleased to announce that it has closed its previously announced and oversubscribed brokered private placement, with Clarus Securities Inc. as sole agent (“Clarus” or the “Agent”), conducted under the Listed Issuer Financing Exemption (as defined herein) (the “Offering”), and has also closed its concurrent non-brokered private placement (the “Concurrent Offering”).

    “We would like to thank all the participants in this oversubscribed financing for their continued support and belief in BluMetric,” said Scott MacFabe, CEO of BluMetric. “This is the first equity raise by the Company in over ten years and marks a new chapter in our journey. The capital infusion will strengthen our balance sheet and provide more flexibility as we execute our long-term growth strategy.”

    The Offering comprised the issuance by the Company of 4,375,000 common shares (the “Offered Shares”) at a price of $0.80 per share, for aggregate gross proceeds of $3,500,000.

    View Full Article Here

     December 13, 2024